Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Aquestive Therapeutics, Inc. AQST

Set alert

Price alert · AQST

All alert types
3.87 USD +0.10 +2.52%

As of Nov 3, 11:50 AM ET

Bid
3.86 × 38
Ask
3.87 × 18
3.78 Day range 3.94
2.93 52-week range 6.85
YTD
-40.17%
1 year
-40.45%
Open
3.78
Prev close
3.77
Mkt cap
485.10M
Vol
507.53K
Avg vol
2.74M
EPS
-0.66
P/E
0.00
Div yield
0.00%
More statistics
Low
3.78
High
3.94
Forward P/E
-5.87
Beta
2.82
Short ratio
6.37
Inst. own
55.98%
Dividend
0.00
Ex-div date
Earnings
Aug 6, 2024
50-d avg
4.68
200-d avg
4.02
1y target
10.83

5D chart

Chart tools
Interval
1m5m15m30m

Signals (52)
NameTimeAgo
MACD: Sell SignalNov 3, 10:25 AM1 hour ago
RSI: OverboughtNov 3, 9:30 AM2 hours ago
SMA: BearishNov 2, 3:55 PM19 hours ago
RSI: OverboughtNov 2, 3:10 PM20 hours ago
SMA: BullishNov 2, 2:40 PM21 hours ago
SMA: BullishNov 2, 2:40 PM21 hours ago
MACD: Buy SignalNov 2, 2:40 PM21 hours ago
MACD: Sell SignalNov 2, 2:25 PM21 hours ago
SMA: BearishNov 2, 1:40 PM22 hours ago
SMA: BearishNov 2, 12:50 PM23 hours ago
SMA: BullishNov 2, 12:25 PM23 hours ago
SMA: BearishNov 2, 12:15 PM23 hours ago
SMA: BullishNov 2, 12:10 PM23 hours ago
MACD: Buy SignalNov 2, 12:10 PM23 hours ago
MACD: Sell SignalNov 2, 12:05 PM23 hours ago
MACD: Buy SignalNov 2, 12:00 PM23 hours ago
RSI: OversoldNov 2, 11:40 AM1 day ago
RSI: OversoldNov 2, 10:35 AM1 day ago
MACD: Sell SignalNov 2, 10:05 AM1 day ago
SMA: BearishNov 2, 9:50 AM1 day ago

Newest 20 of 52.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 10.83 +180.3% upside
Target (low)
5.50
Target (mean)
10.83
Target (high)
17.00
Ratings (0m) 9 9 buy · 0 hold · 0 sell
  • Strong buy4
  • Buy5
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 9
  • 1 month ago 8
  • 2 months ago 8
  • 3 months ago 8

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

AQST analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.1325-0.14 – -0.12-0.0917-44.5%13.11M-0.7%4
Next quarter-0.1325-0.16 – -0.12-0.15+11.7%12.90M+7.0%4
Current year-0.4225-0.50 – -0.33-0.062-581.5%57.50M+13.7%4
Next year-0.5375-0.67 – -0.44-0.4225-27.2%52.97M-7.9%4

Upgrades and downgrades

The latest rating changes

AQST analyst upgrades and downgrades
DateFirmActionFromTo
Dec 20, 2024HC Wainwright & Co.ReiteratedBuyBuy
Dec 17, 2024Cantor FitzgeraldInitiated—Overweight
Nov 11, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 6, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 25, 2024Leerink PartnersMaintainedOutperformOutperform
Oct 25, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 8, 2024JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Sep 30, 2024JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Sep 30, 2024Leerink PartnersReiteratedOutperformOutperform
Sep 30, 2024HC Wainwright & Co.MaintainedBuyBuy
Aug 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 12, 2024JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Jul 26, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 26, 2024JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Jun 5, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 10, 2024Leerink PartnersInitiated—Outperform
May 9, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 30, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 11, 2024Piper SandlerInitiated—Overweight
Apr 5, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 28, 2024Raymond JamesInitiated—Outperform
Mar 18, 2024HC Wainwright & Co.MaintainedBuyBuy
Mar 15, 2024JMP SecuritiesMaintainedOutperformOutperform
Mar 11, 2024HC Wainwright & Co.MaintainedBuyBuy
Mar 7, 2024WedbushMaintainedOutperformOutperform
Mar 7, 2024Lake StreetMaintainedBuyBuy
Nov 8, 2023HC Wainwright & Co.MaintainedBuyBuy
Oct 10, 2023WedbushReiteratedOutperformOutperform
Oct 10, 2023HC Wainwright & Co.ReiteratedBuyBuy
Sep 22, 2023WedbushReiteratedOutperformOutperform